期刊文献+

应用FISH技术检测原发性肺癌P^(53)抑癌基因异常及其临床意义 被引量:3

Detection of P^(53) Gene Deletion in Primary Lung Cancer byFish Technique and its Clinical Significance
暂未订购
导出
摘要 目的 探讨原发性肺癌 P53缺失 /异常表达及临床意义。方法 应用 FISH和免疫组化技术检测 6 5例肺癌间期核中 P53基因异常。结果  P53缺失率为 18.4 % (12 / 6 5 ) ,分化好比分化差者缺失率增高 (P=0 .0 0 7)。 P53蛋白阳性率随着肺癌临床分期增高呈上升趋势 (P=0 .0 4 6 ) ,与年龄、性别、肿瘤大小及分化程度等无相关性 (P>0 .0 5 )。结论  P53基因缺失和蛋白表达与肺癌分化程度、临床分期密切相关 ,检测 Objective To investigate the abnormality of P 53 gene in primary lung cancer and its clinical significance.Methods 65 surgical samples from patients with primary lung cancer were examined for P 53 gene abnormality by FISH technique and immunohistochemical staining.Results P 53 gene deletion was detected in 12 of 65 (18.4%) patients with primary lung cancer,and the rate of gene deletion was higher in good differentiation than in poor differentiation (P=0.007).The positive rate of P 53 protein expression showed positive correlation with clinical stage (P=0.046),but showed no relationship with sex,age,tumor size and histopathological types(P>0.05).Conclusion Detections of P 53 gene was related to differentiation of pathological grades and clinical stage of lung cancer,which might be useful in evaluating patient's prognoses.
出处 《中国误诊学杂志》 CAS 2002年第6期829-832,共4页 Chinese Journal of Misdiagnostics
基金 深圳市卫生科技计划重点攻关项目 (No.1 9980 50 1 1 )资助
关键词 肺肿瘤 P^53基因 基因缺失 荧光原位杂交 免疫组织化学 基因表达 Lung neoplasms/genetics Genes,P 53 Protein P 53 /genetics Gene deletion In situ hybridization,fluorescence
  • 相关文献

参考文献13

  • 1Prives C,Hall PA.The P53 pathway.J Pathol,1999,187(1):112-126
  • 2Valerie Soenen,Claude Preudhomme,Christophe Roumier,et al.17p deletion in acute myeloid leukemia and myelodysplastic syndrome.Analysis of breakpoints and deleted segments by fluorescence in situ.Blood,1998,91(3):1008-1015
  • 3Nanashima A,Tagawa Y,Yasutake T,et al.Analysis of P53 gene deletions in colorectal cancers using fluorescence in situ hybridization.Surg Today,1997,27(11):999-1004
  • 4Yutaka Tagawa,Atsushi Nanashima,Takashi Tsuji,et al.Importance of cytogenetic markers for multiple primary carcinomas in colorectal cancer: Chromosome 17 and P53 locus translocation.J Gasteoenterology,1998,33 (5):670-677
  • 5Li X,Tsuji T,Wen S,et al.Detection of numeric abnormalities of chromosome 17 and P53 deletions by fluorescence in situ hybridization in pleomorphic adenomas and carcinomas in pleomorphic adenoma.Correlation with P53 expression.Cancer,1997,15(79):2314-2319
  • 6Han H,Landreneau RJ,Santucci TS,et al.Prognostic value of immunohistoschemical expressions of P53 HER-2/neu,and bcl-2 in stage 1 non-small-cell lung cancer.Hum Pathol,2002,33(1):105-110
  • 7Marcel Th.M.van Rens,Erik J.E.Eijken,Johannes R.J.Elbers,et al.P53 mutation analysis for definite diagnosis of multiple primary lung carcinoma.Cancer,2002,94(1):188-196
  • 8Iggo R,Gatter K,Bartek J,et al.Increased expression of mutant froms of P53 oncogene in primary lung cancer.Lancel,1990,335 (3):675-679
  • 9Huncharek Kupelinick B,Geschwind JF,et al.Prognostic significance of mutation in non-small cell lung cancer: a meta-analysis of 829 case from eight published studies.Cancer Lett,2000,153(1-2):219-226
  • 10Wiest JS,Franklin WA,Drabkin H,et al.Genetic markers for early detection of lung cancer and outcome measures for response to chemoprevention.J Cell Biochem Suppl,1997,28(29):64-73

同被引文献31

  • 1王晓玫,成志强,陶凤华,苏学劲,王玲.应用SSCP-PCR技术研究非小细胞肺癌p53基因突变[J].第四军医大学学报,2003,24(18):1650-1652. 被引量:2
  • 2谢菁,薛永权,黄建安,王光杰.应用荧光原位杂交技术检测肺癌间期细胞部分染色体数目的改变[J].中国综合临床,2006,22(1):30-33. 被引量:6
  • 3Schmale H,Bamberger C.A novel protein with strong homology to the tumor suppressor p53[J].Oncogene,1997,15(11):1363-1367.
  • 4Persons DL,Bui MM,Lowery MC,et al.Fluorescence in situ hybridization (FISH) for detection of HER-2/neu amplification in breast cancer:a multicenter potability study[J].Ann Clin Lab Sci,2000,30(1):41-48.
  • 5Li X,Tsuji T,Wen S,et al.Detection of numeric abnormalities of chromosome 17 and p53 deletions by fluorescence in situ hybridization in pleomorphic adenomas and carcinomas in pleomorphic adenoma.Correlation with p53 expression[J].Cancer,1997,79(12):2314-2319.
  • 6van Rens MT,Eijken EJ,Elbers JR,et al.p53 mutation analysis for definite diagnosis of multiple primary lung carcinoma[J].Cancer,2002,94(1):188-196.
  • 7Greenblatt MS,Bennett WP,Hollstein M,et al.Mutations in the p53 tumor suppressor gene:clues to cancer etiology and molecular pathogenesis[J].Cancer Res,1994,54(18):4855-4878.
  • 8Yoshioka K,Nakamura S.Chromosome 9 and 17 aberrations and p53 gene deletion detected by fluorescence in situ hybridization in renalcell carcinoma[J].Mol Urol,2001,5(1):11-17.
  • 9Gunther T,Schneider-Stock R Hackel C,et al.MDM2 gene amplification in gastric cancer correlation with expression of MDM2 protein and P53 alterations Mod Pathol,2000,13(6):621-626.
  • 10Takaomi Koga,Shuichi Hashimoto,Kenji Sugio,Heterogeneous distribution of P53 immunoreactivity in human lung adenocarcinoma correlates with MDM2 protein expression,rather than with P53 gene mutation.Internation J Cancer.2001;95:232-239.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部